Houston, TX, United States of America

Dharini Van Der Hoeven

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: The University of Texas System. Active years: 2016-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dharini Van Der Hoeven

Introduction

Dharini Van Der Hoeven is a prominent inventor based in Houston, TX. She has made significant contributions to the field of medical research, particularly in the development of novel therapeutic compounds. With a total of 2 patents to her name, her work focuses on addressing critical health issues.

Latest Patents

Dharini's latest patents include innovative advancements in the treatment of K-ras mediated disorders. One of her notable inventions is related to fendiline derivatives, which involves the preparation and use of novel compounds that can potentially improve treatment outcomes. Additionally, she has developed methods and compositions aimed at identifying and characterizing inhibitors of K-ras localization to the plasma membrane. These compositions hold promise for treating K-ras mediated disorders, including various forms of cancer.

Career Highlights

Dharini is affiliated with the University of Texas System, where she conducts her research and development activities. Her work has garnered attention for its potential impact on cancer treatment and other K-ras related conditions.

Collaborations

Throughout her career, Dharini has collaborated with esteemed colleagues, including John F Hancock and Jia Zhou. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Dharini Van Der Hoeven's contributions to medical research and her innovative patents reflect her dedication to improving health outcomes. Her work continues to inspire advancements in the treatment of serious medical conditions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…